IP Library › Assignment 031475/0613
Patent Assignment
Reel/Frame 031475/0613

Assignment of Assignor's Interest

Recorded: 2013-10-25 Pages: 4
Assignor
BAOBAB PHARMACEUTICALS LIMITED
Executed: 2013-10-18
Assignee
NANJING FRONTIER BIOTECHNOLOGIES CO., LTD.
5 QIANDE ROAD, KEXUE YUAN (SCIENCE PARK), JIANGNING DISTRICT, NANJING, 211122, CHINA
Covered Properties (2)
Human Immunodeficiency Virus (Hiv) GP41 Peptide Derivatives with Enhanced Solubility and Antiviral Activity.
Patent: 7,575,750 →
Application: 10/667,966 →
Publication: US 2005/0089840
Method of Inhibiting Hiv-1 Replication by Administering Modified GP41 C34 Peptide Derivatives with Enhanced Pharmacological Properties
Patent: 8,470,527 →
Application: 12/567,250 →
Publication: US 2011/0003735
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 29, 2004
From: XIE, DONG; JIANG, HE
To: FRONTIER BIOTECHNOLOGIES CO., LTD.
Reel/Frame 015516/0286 →
Assignment of Assignor's Interest Jun 14, 2013
From: FRONTIER BIOTECHNOLOGIES CO., LTD.
To: BAOBAB PHARMACEUTICALS LIMITED
Reel/Frame 030611/0712 →
Change of Name May 16, 2019
From: NANJING FRONTIER BIOTECHNOLOGIES CO., LTD.
To: FRONTIER BIOTECHNOLOGIES INC.
Reel/Frame 049195/0001 →